Stockscreener 앱 받기
0.00
100.00%
-11.82
시간 외 거래:
12.36
12.36
+
전일 마감가:
$11.82
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$311.37M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$12.05
52주 변동 폭
$0.00
$17.80
Vicore Pharma Holding Ab Adr Stock (VCRE) Company Profile
Compare VCRE vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VCRE
Vicore Pharma Holding Ab Adr
|
0.00 | 311.37M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
496.07 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
784.36 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
865.04 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
205.15 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
348.27 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Vicore Pharma Holding Ab Adr 주식(VCRE)의 최신 뉴스
VCRE|Vicore Pharma Holding AB ADR|Price:11.510|Chg%:+0.130 - TradingKey
() Valuation: PE, PB & Fair Value Analysis - TradingKey
() Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
VCRE Balance Sheet - TradingKey
Earnings Income Statement Balance Sheet Cash Flow Statement - TradingKey
TradingKey - TradingKey
() Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
() Institutional Confidence - TradingKey
() Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
VCRE|Vicore Pharma Holding AB ADR|Price:11.380|Chg%:-0.230 - TradingKey
VCRE|Vicore Pharma Holding AB ADR|Price:11.920|Chg%:-0.460 - TradingKey
Ericsson, Q32 Bio And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session - Sahm
Ericsson, Q32 Bio and other big stocks moving lower in Tuesday’s pre-market session - MSN
Citigroup Reports Second Quarter 2026 Results - Business Wire
Porch Group, Micron And Other Big Stocks Moving Lower In Monday’s Pre-Market Session - Sahm
Free cash flow per share of Vicore Pharma Holding AB Sponsored ADR – FWB:6Y40 - TradingView
Total revenue of Vicore Pharma Holding AB Sponsored ADR – FWB:6Y40 - TradingView
Total operating expenses of Vicore Pharma Holding AB Sponsored ADR – FWB:6Y40 - TradingView
Vicore Pharma Holding AB Sponsored ADR Earnings and Revenue – FWB:6Y40 - TradingView
Vicore Pharma Holding AB (publ) (VCRE) stock price, news, quote and history - Yahoo Finance UK
Citi named depositary bank for Vicore Pharma’s US shares - scanx.trade
Vicore Pharma Holding AB ADR (VCRE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Vicore Pharma Holding AB ADR (VCRE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
Vicore Pharma Holding AB ADR (VCRE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Vicore Pharma Holding AB ADR (VCRE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Vicore Pharma Holding AB ADR (VCRE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Vicore Pharma Holding AB ADR - TradingKey
Vicore Pharma Holding AB ADR (VCRE) Institutional Confidence - TradingKey
VCRE|Vicore Pharma Holding AB ADR|Price:14.124|Chg%:-0.901 - TradingKey
VCRE|Vicore Pharma Holding AB ADR|Price:13.780|Chg%:-0.135 - TradingKey
Citibank Announces $1.5 Billion Redemption of 4.929% Notes Due 2026 and $1 Billion Redemption of Floating Rate Notes Due 2026 - Business Wire
Vicore Pharma to Commence Trading in the United States on the Nasdaq Stock Market - Yahoo Finance
Vicore Pharma Pursues US Dual Listing, Files Registration Statement with the SEC - ACCESS Newswire
Citi Announces 2026 Investor Day - Business Wire
Citi Announces Offers to Purchase Three Series of Outstanding Citigroup Inc. Notes - Business Wire
Citi Appointed as Depositary Bank for Rightmove Plc’s ADR Program - Business Wire
Citigroup Reports First Quarter 2026 Results - Business Wire
Citi Lowers Base Rate - Business Wire
Citigroup Reports First Quarter 2025 Results - Business Wire
Citi Aligns Organizational Structure With Its Strategy and Simplifies Operating Model - Business Wire
Citigroup Declares Common Stock Dividend - Business Wire
Citigroup (C) Stock News & Updates - Stock Titan
Vicore Pharma Holding AB (publ) (VICO.ST) stock price, news, quote and history - Yahoo Finance UK
Vicore Pharma Holding AB (publ) (VICO.ST) Stock Price, News, Quote & History - Yahoo! Finance Canada
C Stock Price | Analyst Target 152.00 & Strong Buy Consensus - eToro
Vicore Pharma Holding Ab Adr (VCRE) 재무 분석
Vicore Pharma Holding Ab Adr (VCRE)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.84%
0.86%
자본화:
|
볼륨(24시간):